336 related articles for article (PubMed ID: 20862817)
1. Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly.
Halshtok O; Goitein O; Abu Sham'a R; Granit H; Glikson M; Konen E
Isr Med Assoc J; 2010 Jul; 12(7):391-5. PubMed ID: 20862817
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience.
Goldsher D; Amikam S; Boulos M; Suleiman M; Shreiber R; Eran A; Goldshmid Y; Mazbar R; Roguin A
Isr Med Assoc J; 2006 Feb; 8(2):91-4. PubMed ID: 16544729
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla.
Gimbel JR
Pacing Clin Electrophysiol; 2008 Jul; 31(7):795-801. PubMed ID: 18684275
[TBL] [Abstract][Full Text] [Related]
4. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan.
Mollerus M; Albin G; Lipinski M; Lucca J
Pacing Clin Electrophysiol; 2008 Oct; 31(10):1241-5. PubMed ID: 18811802
[TBL] [Abstract][Full Text] [Related]
5. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan.
Mollerus M; Albin G; Lipinski M; Lucca J
Pacing Clin Electrophysiol; 2009 Jun; 32(6):772-8. PubMed ID: 19545340
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging in patients with implantable cardiac devices.
Sierra M; Machado C
Rev Cardiovasc Med; 2008; 9(4):232-8. PubMed ID: 19122581
[TBL] [Abstract][Full Text] [Related]
7. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
Russo RJ
Am Heart J; 2013 Mar; 165(3):266-72. PubMed ID: 23453091
[TBL] [Abstract][Full Text] [Related]
8. Cardiac pacemakers and implantable cardioverter defibrillators: in vitro magnetic resonance imaging evaluation at 1.5-tesla.
Shellock FG; Fischer L; Fieno DS
J Cardiovasc Magn Reson; 2007; 9(1):21-31. PubMed ID: 17178677
[TBL] [Abstract][Full Text] [Related]
9. Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices.
Buendía F; Cano Ó; Sánchez-Gómez JM; Igual B; Osca J; Sancho-Tello MJ; Olagüe J; Salvador A
Europace; 2011 Apr; 13(4):533-8. PubMed ID: 21227955
[TBL] [Abstract][Full Text] [Related]
10. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations.
Sommer T; Naehle CP; Yang A; Zeijlemaker V; Hackenbroch M; Schmiedel A; Meyer C; Strach K; Skowasch D; Vahlhaus C; Litt H; Schild H
Circulation; 2006 Sep; 114(12):1285-92. PubMed ID: 16966587
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices.
Roguin A; Schwitter J; Vahlhaus C; Lombardi M; Brugada J; Vardas P; Auricchio A; Priori S; Sommer T
Europace; 2008 Mar; 10(3):336-46. PubMed ID: 18308754
[TBL] [Abstract][Full Text] [Related]
12. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs).
Gimbel JR; Kanal E; Schwartz KM; Wilkoff BL
Pacing Clin Electrophysiol; 2005 Apr; 28(4):270-3. PubMed ID: 15826257
[TBL] [Abstract][Full Text] [Related]
13. MR in patients with pacemakers and ICDs: Defining the issues.
Shinbane JS; Colletti PM; Shellock FG
J Cardiovasc Magn Reson; 2007; 9(1):5-13. PubMed ID: 17178675
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.
Naehle CP; Strach K; Thomas D; Meyer C; Linhart M; Bitaraf S; Litt H; Schwab JO; Schild H; Sommer T
J Am Coll Cardiol; 2009 Aug; 54(6):549-55. PubMed ID: 19643318
[TBL] [Abstract][Full Text] [Related]
15. Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices.
Baikoussis NG; Apostolakis E; Papakonstantinou NA; Sarantitis I; Dougenis D
Ann Thorac Surg; 2011 Jun; 91(6):2006-11. PubMed ID: 21531377
[TBL] [Abstract][Full Text] [Related]
16. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers.
Pulver AF; Puchalski MD; Bradley DJ; Minich LL; Su JT; Saarel EV; Whitaker P; Etheridge SP
Pacing Clin Electrophysiol; 2009 Apr; 32(4):450-6. PubMed ID: 19335853
[TBL] [Abstract][Full Text] [Related]
17. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T.
Naehle CP; Kreuz J; Strach K; Schwab JO; Pingel S; Luechinger R; Fimmers R; Schild H; Thomas D
Am Heart J; 2011 Jun; 161(6):1096-105. PubMed ID: 21641356
[TBL] [Abstract][Full Text] [Related]
18. Not all pacemakers are created equal: MRI conditional pacemaker and lead technology.
Ahmed FZ; Morris GM; Allen S; Khattar R; Mamas M; Zaidi A
J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1059-65. PubMed ID: 24016320
[TBL] [Abstract][Full Text] [Related]
19. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
Ubee SS; Kasi VS; Bello D; Manikandan R
J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
[TBL] [Abstract][Full Text] [Related]
20. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
Cohen JD; Costa HS; Russo RJ
Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
